HCN News Team – Page 91 – Highly Capitalized

Sunday, October 25, 2026 We Follow The Money.

About HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

HYTN Secures Health Canada Drug Licence to Propel Cannabinoid Prescription Drug Pathway

HCN News Team2025-07-16T02:36:12-08:00July 16th, 2025|Capital, Insights, International|

LOS ANGELES- Vancouver-based HYTN Innovations Inc. (CSE: HYTN; OTC Pink: HYTNF) announced on ...

AYR Wellness Secures Extension of Debt Waiver Ahead of Financial Deadline

HCN News Team2025-07-16T02:33:23-08:00July 16th, 2025|Business, Insights|

LOS ANGELES- AYR Wellness Inc. a vertically integrated multi-state cannabis ...

Americans Overwhelmingly Oppose Federal Cannabis Prohibition

HCN News Team2025-07-16T02:30:56-08:00July 16th, 2025|Insights, Policy|

LOS ANGELES- A recent survey by the Pew Research Center ...

Republican Lawmakers Move to Block Cannabis Rescheduling, Undermining Federal Reform Efforts

HCN News Team2025-07-15T18:41:15-08:00July 15th, 2025|Business, Policy|

WASHINGTON, D.C.. Just as the Biden administration’s long-awaited cannabis rescheduling ...

MariMed Expands Access to Betty’s Eddies Chews to Medical Market in Maine

HCN News Team2025-07-15T04:52:49-08:00July 15th, 2025|Brands, Capital|

LOS ANGELES- MariMed Inc. has entered into a licensing agreement ...

Senate Panel Flags Misleading Cannabis Marketing, Backs Psychedelics Research

HCN News Team2025-07-15T04:48:47-08:00July 15th, 2025|Insights|

LOS ANGELES- The Senate Appropriations Committee released a report accompanying ...

McConnell Seeks to Close 2018 Hemp “Loophole” in Senate Funding Bill

HCN News Team2025-07-15T04:36:09-08:00July 15th, 2025|Insights, Policy|

LOS ANGELES- Senate Republican leader Mitch McConnell is advancing a ...

Psilocybin Study Suggests Potential for Longevity Benefits

HCN News Team2025-07-14T09:14:58-08:00July 14th, 2025|News, Psychedelics|

LOS ANGELES- New preclinical research indicates that psilocybin the active ...

Challenges Emerge Over Kentucky’s Medical Cannabis License Lottery

HCN News Team2025-07-14T09:10:39-08:00July 14th, 2025|Insights, Policy|

LOS ANGELES- A coalition of Kentucky-based businesses has filed legal ...

Aegis Capital Maintains Buy Rating on atai Life Sciences with $8 Target

HCN News Team2025-07-14T09:06:06-08:00July 14th, 2025|Business|

LOS ANGELES- Aegis Capital has reaffirmed its Buy rating on ...

Previous 909192 Next

DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more

HCN Media Group | 171 Pier Avenue, Suite 177, Santa Monica, California, 90405

© Copyright | Highly Capitalized | All Rights Reserved | Website by Vadimages.